verified SJR 1,743 · Q1 • database Scopus / SJR & Web of Science indexed

Netherlands · SAGE Publications Ltd

workspace_premium Q1 — Neurology (clinical) lock Subscription

Journal of Parkinson's Disease

Journal of Parkinson's Disease is a journal indexed in SJR in Neurology (clinical) and Cellular and Molecular Neuroscience with an H index of 75. It has an SJR impact factor of 1,743 and it has a best quartile of Q1. It has an SJR impact factor of 1,743.

ISSN: 1877-7171

Publisher: SAGE Publications Ltd

Category: Neurology (clinical)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,743 Q1

H-index 75

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,743

H-index

Docs (year)

174

Docs 3y

540

Total refs

9636

Cites 3y

2647

Citable 3y

519

Cites/Doc 2y

4.64

Ref/Doc

55.38

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Can Cognitive Remediation Improve Mobility in Patients with Parkinson's Disease? Findings from a 12 week Pilot Study

Which Patients with Parkinson's Disease Participate in Clinical Trials? One Centre's Experiences with a New Cell Based Therapy Trial (TRANSEURO)

E-health Support in People with Parkinson's Disease with Smart Glasses: A Survey of User Requirements and Expectations in the Netherlands

Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?

Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use

Design and Evaluation of Levodopa Methyl Ester Intranasal Delivery Systems

Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's Disease

CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON'S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

Clinical Implication of REM Sleep Behavior Disorder in Parkinson's Disease

Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function

Choosing an Advanced Therapy in Parkinson's Disease; is it an Evidence-Based Decision in Current Practice?

SHOW MORE ARTICLES

Challenges of Improving Patient-Centred Care in Parkinson's Disease

A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models

Automatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson's Disease

Asymmetry of Periodic Leg Movements in Sleep (PLMS) in Parkinson's Disease

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease

Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson's disease

APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression

Amphetamine-Induced Dyskinesia in the Transplanted Hemi-Parkinsonian Mouse

Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model

Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease

Acute Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or Paraquat on Core Temperature in C57BL/6J Mice

A Survey of Parkinson's Disease Patients: Most Bothersome Symptoms and Coping Preferences

FAQs

Journal of Parkinson's Disease has an SJR of 1,743 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Parkinson's Disease is 30%.

Journal of Parkinson's Disease

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Parkinson's Disease?

What is the APC / publication cost?

What is the acceptance rate?